Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians

  1. Amir Qaseem, MD, PhD, MHA;
  2. Vincenza Snow, MD;
  3. Thomas D. Denberg, MD, PhD;
  4. Donald E. Casey, Jr., MD, MPH, MBA;
  5. Mary Ann Forciea, MD;
  6. Douglas K. Owens, MD, MS;
  7. Paul Shekelle, MD, PhD; and
  8. for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians*
  1. From the American College of Physicians and University of Pennsylvania, Philadelphia, Pennsylvania; University of Colorado, Aurora, Colorado; Atlantic Health, Morristown, New Jersey; Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, California; and Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.
    1. Figure.
      View larger version:
      Figure. The American College of Physicians guideline on hormonal testing and pharmacologic treatment of erectile dysfunction.

      PDE-5 = phosphodiesterase-5.

    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med November 3, 2009 vol. 151 no. 9 639-649
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
    5. CME Course

    Rapid Responses

    1. Submit a response
    2. No responses published

    Google Scholar

    1. Articles by Qaseem, A.

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues